A clinically and functionally relevant definition of an asthma exacerbation will be invaluable in the assessment of the severity of such an event and the streamlining of the steps necessary to ...

Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.

GSK plc has announced that new drug applications have been accepted for review by the China National Medical Products ...

Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...

Dr. Neha Reshamwala, owner of Frontier Allergy, Asthma & Immunology, with BioBehavioral Research of Austin (BBRA) stopped by ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

Even if you don't live in an area where wildfires are typical, it's important to know how to protect your health.

These conditions are commonly misdiagnosed for anxiety when they are really something far more serious than that ...

If approved, GSK's depemokimab will be the first ultra-long-acting biologic that requires only one dose every six months.

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.